Stimulant and non‐stimulant attention deficit/hyperactivity disorder drug use: total population study of trends and discontinuation patterns 2006–2009
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Zetterqvist J, Asherson P, Halldner L, Långström N, Larsson H. Stimulant and non‐stimulant attention deficit/hyperactivity disorder drug use: total population study of trends and discontinuation patterns 2006–2009. Objective: To explore the prevalence and discontinuation of dispensed medications for attention deficit/hyperactivity disorder (ADHD) drugs from 2006 to 2009. Method: A total population cohort of all individuals aged 6–45 years, alive and registered as residents in Sweden during any calendar year from 2006 to 2009 (N = 5 149 791) included 41 700 patients dispensed with an ADHD drug (methylphenidate, atomoxetine, amphetamine, or dexamphetamine). The dispensing prevalence was calculated for each year, stratified on sex and age. A longitudinal analysis was also performed to compare the rates of treatment discontinuation across the strata. Results: The dispensing prevalence increased from 2.93 per 1000 in 2006 to 6.98 in 2009 (PR = 2.38, 95% CI = 2.34–2.43). The prevalence ratio (PR) was 3.40 for adults, 22–45 years old; 2.41 for adolescents, 15–21 years old; and 1.90 for children aged 6–14. The increase was also greater in women than in men (PR = 2.92 vs. 2.19). Patients aged 15–21 were the most likely to discontinue treatment; after 3 years and 11 months, 27% of those patients were still under treatment. Conclusion: From 2006 to 2009, the number of prescriptions dispensed for ADHD drugs increased substantially. The rate of treatment discontinuation in the age interval 15–21 is higher than expected considering the persistence rates of the disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886 · cited 1×
“6 reported earlier from population-based studies of ADHD in adults (2, 3).”
BackgroundFARAONE, S. V., BIEDERMAN, J., & MICK, E. (2006) · Psychological Medicine · doi:10.1017/s003329170500471x · Cited by 2,267
Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis
Simon, V., Czobor, P., Bálint, S., Mészáros, Á., & Bitter, I. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.048827 · Cited by 1,601
Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder
Fayyad, J., De Graaf, R., Kessler, R., Alonso, J., Angermeyer, M., Demyttenaere, K., De Girolamo, G., Haro, J. M., Karam, E. G., Lara, C., et al. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.034389 · Cited by 1,321 · cited 1×
“6 reported earlier from population-based studies of ADHD in adults (2, 3).”
BackgroundMolina, B. S. G., Hinshaw, S. P., Swanson, J. M., Arnold, L. E., Vitiello, B., Jensen, P. S., Epstein, J. N., Hoza, B., Hechtman, L., Abikoff, H. B., et al. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31819c23d0 · Cited by 1,182
Gender Differences in ADHD: A Meta-Analysis and Critical Review
GAUB, M., & CARLSON, C. L. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199708000-00011 · Cited by 1,117
Kooij, S. J., Bejerot, S., Blackwell, A., Caci, H., Casas-Brugué, M., Carpentier, P. J., Edvinsson, D., Fayyad, J., Foeken, K., Fitzgerald, M., et al. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-67 · Cited by 928
Self-citationHow persistent is ADHD? A controlled 10-year follow-up study of boys with ADHD
Biederman, J., Petty, C. R., Evans, M., Small, J., & Faraone, S. V. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.12.010 · Cited by 496
Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD
GREENHILL, L., KOLLINS, S., ABIKOFF, H., MCCRACKEN, J., RIDDLE, M., SWANSON, J., MCGOUGH, J., WIGAL, S., WIGAL, T., VITIELLO, B., et al. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000235077.32661.61 · Cited by 467
Cited by
ADHD in Children and Young People: Prevalence, Care Pathways, and Service Provision
Sayal, K., Prasad, V., Daley, D., Ford, T., & Coghill, D. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30167-0 · Cited by 1,223
Medication for Attention Deficit–Hyperactivity Disorder and Criminality
Lichtenstein, P., Halldner, L., Zetterqvist, J., Sjölander, A., Serlachius, E., Fazel, S., Långström, N., & Larsson, H. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203241 · Cited by 611
Self-citationPharmacologic Treatment of Attention Deficit–Hyperactivity Disorder
Cortese, S. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1917069 · Cited by 342
Chang, Z., Lichtenstein, P., D’Onofrio, B. M., Sjölander, A., & Larsson, H. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.4174 · Cited by 293
Self-citationGender differences in adults with attention-deficit/hyperactivity disorder: A narrative review
Williamson, D., & Johnston, C. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.05.005 · Cited by 226
Stimulant ADHD medication and risk for substance abuse
Chang, Z., Lichtenstein, P., Halldner, L., D'Onofrio, B., Serlachius, E., Fazel, S., Långström, N., & Larsson, H. (2014) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12164 · Cited by 225
“Journal of Child Psychology and Psychiatry © 2013 Association for Child and Adolescent Mental Health. prescriptions of ADHD medication, unless prescriptions occurred more than 6 months apart (Lichtenstein et al., 2012; Zetterqvist et al., 2012).”
Self-citationThe familial co-aggregation of ASD and ADHD: a register-based cohort study
Ghirardi, L., Brikell, I., Kuja-Halkola, R., Freitag, C. M., Franke, B., Asherson, P., Lichtenstein, P., & Larsson, H. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.17 · Cited by 220
Self-citationChen, Q., Sjolander, A., Runeson, B., D'Onofrio, B. M., Lichtenstein, P., & Larsson, H. (2014) · BMJ · doi:10.1136/bmj.g3769 · Cited by 170
Self-citationHuybrechts, K. F., Bröms, G., Christensen, L. B., Einarsdóttir, K., Engeland, A., Furu, K., Gissler, M., Hernandez-Diaz, S., Karlsson, P., Karlstad, Ø., et al. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.3644 · Cited by 142
Larsson, H., Sariaslan, A., Långström, N., D'Onofrio, B., & Lichtenstein, P. (2014) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12140 · Cited by 126
Self-citationRydell, M., Lundström, S., Gillberg, C., Lichtenstein, P., & Larsson, H. (2018) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12882 · Cited by 105
Self-citationGiacobini, M., Medin, E., Ahnemark, E., Russo, L. J., & Carlqvist, P. (2018) · Journal of Attention Disorders · doi:10.1177/1087054714554617 · Cited by 94
“Pharmacological treatment is not recommended in children with ADHD below the age of 6 in Sweden (Zetterqvist et al., 2013), which may explain the lower proportion of treated individuals within this age group.”
BackgroundMethodResultInfluentialAttention-Deficit/Hyperactivity Disorder and Risk for Substance Use Disorders in Relatives
Skoglund, C., Chen, Q., Franck, J., Lichtenstein, P., & Larsson, H. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.10.006 · Cited by 70
Self-citationPolyzoi, M., Ahnemark, E., Medin, E., & Ginsberg, Y. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s155838 · Cited by 69
Gender and injuries predict stimulant medication use
Dalsgaard, S., Leckman, J. F., Nielsen, H. S., & Simonsen, M. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0101 · Cited by 40
Meyer, J., Ramklint, M., Hallerbäck, M. U., Lööf, M., & Isaksson, J. (2022) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-021-01753-2 · Cited by 28
“Moreover, we had a relatively large dropout, which is partly in line with previous studies and may reflect the nature of the disorder [26, 53].”
ResultAhlberg, R., Du Rietz, E., Ahnemark, E., Andersson, L. M., Werner-Kiechle, T., Lichtenstein, P., Larsson, H., & Garcia-Argibay, M. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04713-z · Cited by 27
Self-citationOveruse of methylphenidate: an analysis of Swedish pharmacy dispensing data
Bjerkeli, P. J., Perez Vicente, R., Mulinari, S., Johnell, K., & Merlo, J. (2018) · Clinical Epidemiology · doi:10.2147/clep.s178638 · Cited by 18
Combined Medication with Stimulants and Non-Stimulants for Attention-Deficit/Hyperactivity Disorder
Bahn, G. H., & Seo, K. (2021) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2021.19.4.705 · Cited by 8
Metadata
- Authors
- Zetterqvist, J., Asherson, P., Halldner, L., Långström, N., & Larsson, H.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 2012-09-04
- Volume
- 128
- Issue
- 1
- Pages
- 70-77
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W1608645544
- Cited by
- 152
- References
- 19
- FWCI
- 7.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.